Robeco Institutional Asset Management B.V. Grows Holdings in HealthStream, Inc. (NASDAQ:HSTM)

Robeco Institutional Asset Management B.V. raised its position in shares of HealthStream, Inc. (NASDAQ:HSTM - Free Report) by 26.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 76,260 shares of the technology company's stock after purchasing an additional 16,166 shares during the period. Robeco Institutional Asset Management B.V. owned approximately 0.25% of HealthStream worth $2,425,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Barclays PLC grew its holdings in shares of HealthStream by 145.0% during the 3rd quarter. Barclays PLC now owns 58,838 shares of the technology company's stock valued at $1,697,000 after purchasing an additional 34,821 shares during the last quarter. State Street Corp grew its stake in shares of HealthStream by 1.2% during the third quarter. State Street Corp now owns 974,235 shares of the technology company's stock valued at $28,097,000 after buying an additional 11,976 shares during the last quarter. Harbor Capital Advisors Inc. grew its stake in shares of HealthStream by 141.2% during the third quarter. Harbor Capital Advisors Inc. now owns 400,033 shares of the technology company's stock valued at $11,537,000 after buying an additional 234,148 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in shares of HealthStream by 18.7% in the third quarter. JPMorgan Chase & Co. now owns 57,204 shares of the technology company's stock worth $1,650,000 after buying an additional 9,017 shares during the period. Finally, FMR LLC lifted its stake in shares of HealthStream by 24.0% in the 3rd quarter. FMR LLC now owns 119,067 shares of the technology company's stock valued at $3,434,000 after acquiring an additional 23,055 shares during the last quarter. Institutional investors own 69.58% of the company's stock.

Analyst Ratings Changes

HSTM has been the topic of several recent research reports. Canaccord Genuity Group raised their price target on HealthStream from $28.00 to $29.00 and gave the stock a "hold" rating in a research report on Wednesday, October 23rd. Barclays raised their price target on shares of HealthStream from $32.00 to $34.00 and gave the stock an "overweight" rating in a report on Wednesday, October 23rd. Craig Hallum raised shares of HealthStream to a "strong-buy" rating in a research note on Thursday, October 17th. Finally, JMP Securities restated a "market perform" rating on shares of HealthStream in a report on Thursday. Two research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, HealthStream presently has an average rating of "Moderate Buy" and a consensus price target of $31.50.

HealthStream Stock Performance

Shares of NASDAQ HSTM traded up $0.13 during midday trading on Friday, hitting $33.18. 88,241 shares of the company traded hands, compared to its average volume of 114,190. HealthStream, Inc. has a 12-month low of $23.92 and a 12-month high of $33.78. The firm has a market cap of $1.01 billion, a P/E ratio of 51.05, a P/E/G ratio of 4.25 and a beta of 0.39. The stock has a 50-day moving average price of $32.19 and a 200 day moving average price of $30.35.

HealthStream Company Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.